The link you posted is to last years presentation Wensday October 12 this year wensday is the 10th and the ACRM is in Vancouver not in Atlanta. I am not sure why there site has the cross headings but what you have listed was last year.
It's not strange. Geron had stated at the time of announcement of its decision to divest that the testing for the OPC1 trial would be continued till end of (I guess) August 2012. That data once analyzed must be presented. If this data is very encouraging, it will be a significant plus for the divestment of the stem-cell portfolio. Let us hope it's so.